Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues
Premiums	$ 12,736	$ 11,603
Net investment income	238	290
TOTAL REVENUES	65,502	57,255
Benefits and expenses
Pharmacy and other service costs	48,398	41,431
Medical costs and other benefit expenses	10,498	9,440
Selling, general and administrative expenses	4,213	3,705
Amortization of acquired intangible assets	422	423
TOTAL BENEFITS AND EXPENSES	63,531	54,999
Income from operations	1,971	2,256
Interest expense and other	(362)	(322)
Gain (loss) on sale of businesses	41	(19)
Net investment losses	(2)	(1,836)
Income before income taxes	1,648	79
TOTAL INCOME TAXES	239	291
Net income (loss)	1,409	(212)
Less: Net income attributable to noncontrolling interests	86	65
SHAREHOLDERS' NET INCOME (LOSS)	$ 1,323	$ (277)
Shareholders' net income (loss) per share
Basic (in dollars per share)	$ 4.88	$ (0.97)
Diluted (in dollars per share)	$ 4.85	$ (0.97)
Pharmacy revenues
Revenues
Revenue from contract with customer	$ 48,633	$ 42,036
Fees and other revenues
Revenues
Revenue from contract with customer	$ 3,895	$ 3,326